Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis

References

• Steuer CE, El-Deiry M, Parks JR, et al. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50.
   PubMed Web of Science ®Google Scholar
• Herrera-Gómez A, Villavicencio-Valencia V, Rascón-Ortiz M, et al. Demographic data of laryngeal cancer at the Instituto Nacional de Cancerología in Mexico City. Cir Cir. 2009;77(5):353–357.
   PubMed Web of Science ®Google Scholar
• Bradley PJ. Laryngeal cancer in nondrinker nonsmoker young patients: a distinct pathological entity? Curr Opin Otolaryngol Head Neck Surg. 2016;24(2):140–147.
   PubMed Web of Science ®Google Scholar
• Obid R, Redlich M, Tomeh C. The Treatment of Laryngeal Cancer. Oral Maxillofac Surg Clin North Am. 2019;31(1):1–11.
   PubMed Web of Science ®Google Scholar
• Ding QS, Zhang L, Wang BC, et al. Aberrant high expression level of MORC2 is a common character in multiple cancers. Hum Pathol. 2018;76:58–67.
   PubMed Web of Science ®Google Scholar
• Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106–116.
   PubMed Web of Science ®Google Scholar
• Salih H, Gong W, He S, et al. Long non-coding RNAs and their potential functions in Ligon-lintless-1 mutant cotton during fiber development. BMC Genomics. 2019;20(1):661.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Li L, et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. Biochem Cell Biol. 2018;96(1):38–43.
   PubMedGoogle Scholar
• Zhang YX, Yuan J, Gao ZM, et al. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway. Eur Rev Med Pharmacol Sci. 2018;22(2):443–449.
   PubMed Web of Science ®Google Scholar
• Lyu K, Xu Y, Yue H, et al. Long Noncoding RNA GAS5 Acts As A Tumor Suppressor In Laryngeal Squamous Cell Carcinoma Via miR-21. Cancer Manag Res. 2019;11:8487–8498.
   PubMed Web of Science ®Google Scholar
• Wen C, Yang S, Zheng S, et al. Analysis of long non-coding RNA profiled following MC-LR-induced hepatotoxicity using high-throughput sequencing. J Toxicol Environ Health A. 2018;81(22):1165–1172.
   PubMed Web of Science ®Google Scholar
• Safarpour-Dehkordi M, Doosti A, Jami MS. Integrative Analysis of lncRNAs in Kidney Cancer to Discover A New lncRNA (LINC00847) as A Therapeutic Target for Staphylococcal Enterotoxin tst Gene. Cell J. 2020;22(Suppl 1):101–109.
   PubMedGoogle Scholar
• Dai Y, Zang Y, Li J, et al. miR-181a and miR-203 inhibit migration and invasion of laryngeal carcinoma cells by interacting with ATF2. Int J Clin Exp Pathol. 2019;12(1):133–141.
   PubMed Web of Science ®Google Scholar
• Li Q, Ma L, Wu Z, et al. Zinc finger E‑box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma. Mol Med Rep. 2019;19(6):4545–4552.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Kumari R, Luthra PM. A reliable fluorimetric method to screen the nitric oxide synthase inhibitors in 96 well plate. Anal Biochem. 2019;577:42–44.
   PubMed Web of Science ®Google Scholar
• Lin G, Huang J, Zhang M, et al. Chitosan-Crosslinked Low Molecular Weight PEI-Conjugated Iron Oxide Nanoparticle for Safe and Effective DNA Delivery to Breast Cancer Cells. Nanomaterials (Basel). 2022;12(4):584.
   PubMedGoogle Scholar
• Rostami M, Kharajo RS, Parsa-Kondelaji M, et al. Altered expression of NEAT1 variants and P53, PTEN, and BCL-2 genes in patients with acute myeloid leukemia. Leuk Res. 2022;115:106807.
   PubMed Web of Science ®Google Scholar
• Stossi F, Singh PK, Mistry RM, et al. Quality Control for Single Cell Imaging Analytics Using Endocrine Disruptor-Induced Changes in Estrogen Receptor Expression. Environ Health Perspect. 2022;130(2):27008.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Ju Q, Ji J, et al. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma. Front Mol Biosci. 2022;9:842833.
   PubMed Web of Science ®Google Scholar
• Samaddar S, Purkayastha S, Diallo S, et al. The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus. Int J Mol Sci. 2022;23(4):1962.
   PubMed Web of Science ®Google Scholar
• Xie H, Sha S, Lu L, et al. Cerium-Containing Bioactive Glasses Promote In Vitro Lymphangiogenesis. Pharmaceutics. 2022;14(2):225.
   PubMed Web of Science ®Google Scholar
• Du J, Xu Q, Zhao H, et al. PI3K inhibitor 3-MA promotes the antiproliferative activity of esomeprazole in gastric cancer cells by downregulating EGFR via the PI3K/FOXO3a pathway. Biomed Pharmacothe. 2022;148:112665.
   PubMed Web of Science ®Google Scholar
• Li W, Xuemei G, Yilin Z, et al. Anticancer effects of Pimaric acid is mediated via endoplasmic reticulum stress, caspase-dependent apoptosis, cell cycle arrest, and inhibition of cell migration in human ovarian cancer cells. Acta Biochim Pol. 2022. DOI:10.18388/abp.2020_6011
   Web of Science ®Google Scholar
• Zhou C, Fan Z, Zhou Z, et al. Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. J Med Chem. 2022;65(5):3923–3942.
   PubMed Web of Science ®Google Scholar
• Yang Z, Shi X, Gao Z, et al. miR-155-5p in Extracellular Vesicles Derived from Choroid Plexus Epithelial Cells Promotes Autophagy and Inflammation to Aggravate Ischemic Brain Injury in Mice. Oxid Med Cell Longev. 2022;2022:8603427.
   PubMed Web of Science ®Google Scholar
• Chen H, Yu Y, Yang M, et al. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner. Cell Biosci. 2022;12(1):19.
   PubMed Web of Science ®Google Scholar
• Yoshikawa H, Nishino K, Kosako H. Identification and validation of new ERK substrates by phosphoproteomic technologies including Phos-tag SDS-PAGE. J Proteomics. 2022;258:104543.
   PubMed Web of Science ®Google Scholar
• W-h L, de Souto Barreto P, Rolland Y, et al. Biological and Neuroimaging Markers as Predictors of 5-Year Incident Frailty in Older Adults: a Secondary Analysis of the MAPT Study. J Gerontol A Biol Sci Med Sci. 2021;76(11):e361–e369.
   PubMed Web of Science ®Google Scholar
• Xi X, Hu Z, Wu Q, et al. High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling. Bioengineered. 2022;13(1):1895–1907.
   PubMed Web of Science ®Google Scholar
• Tan D, Li G, Zhang P, et al. LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells. Bioengineered. 2022;13(1):1838–1857.
   PubMed Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–1789.
   PubMed Web of Science ®Google Scholar
• Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25(18):1915–1927.
   PubMed Web of Science ®Google Scholar
• Guttman M, Russell P, Ingolia NT, et al. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell. 2013;154(1):240–251.
   PubMed Web of Science ®Google Scholar
• Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106(28):11667–11672.
   PubMed Web of Science ®Google Scholar
• Cabili MN, Dunagin MC, McClanahan PD, et al. Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol. 2015;16(1):20.
   PubMedGoogle Scholar
• Werner MS, Ruthenburg AJ. Nuclear Fractionation Reveals Thousands of Chromatin-Tethered Noncoding RNAs Adjacent to Active Genes. Cell Rep. 2015;12(7):1089–1098.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu N, Wang J, et al. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. J Cell Mol Med. 2019;23(10):6708–6719.
   PubMed Web of Science ®Google Scholar
• Xu Z, Xi K. LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis. Biomed Pharmacother. 2019;118:109222.
   PubMed Web of Science ®Google Scholar
• Zhao D, Hou Y. Long non-coding RNA nuclear-enriched abundant transcript 1 (LncRNA NEAT1) upregulates Cyclin T2 (CCNT2) in laryngeal papilloma through sponging miR-577/miR-1224-5p and blocking cell apoptosis. Bioengineered. 2022;13(1):1828–1837.
   PubMed Web of Science ®Google Scholar
• Cybula M, Wieteska £, Józefowicz-Korczyńska M, et al. New miRNA expression abnormalities in laryngeal squamous cell carcinoma. Cancer Biomark. 2016;16(4):559–568.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu J, Hu W, et al. miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma. Onco Targets Ther. 2019;12:10441–10453.
   PubMedGoogle Scholar
• Zhou ZX, Zhang ZP, Tao ZZ, et al. miR-632 Promotes Laryngeal Carcinoma Cell Proliferation, Migration, and Invasion Through Negative Regulation of GSK3β. Oncol Res. 2020;28(1):21–31.
   PubMed Web of Science ®Google Scholar
• Shen H, Weng XD, Liu XH, et al. miR-181a-5p is downregulated and inhibits proliferation and the cell cycle in prostate cancer. Int J Clin Exp Pathol. 2018;11(8):3969–3976.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang W, Ji W. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma. Future Oncol. 2018;14(17):1741–1753.
   PubMed Web of Science ®Google Scholar
• Wang HT, Tong X, Zhang ZX, et al. MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway. Febs J. 2019;286(19):3892–3908.
   PubMed Web of Science ®Google Scholar
• Sun DK, Wang JM, Zhang P, et al. MicroRNA-138 Regulates Metastatic Potential of Bladder Cancer Through ZEB2. Cell Physiol Biochem. 2015;37(6):2366–2374.
   PubMedGoogle Scholar
• Shi ZM, Wang L, Shen H, et al. Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling. Oncogene. 2017;36(18):2577–2588.
   PubMed Web of Science ®Google Scholar
• Quintes S, Brinkmann BG, Ebert M, et al. Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nat Neurosci. 2016;19(8):1050–1059.
   PubMed Web of Science ®Google Scholar
• Li MZ, Wang JJ, Yang SB, et al. ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer. Am J Transl Res. 2017;9(6):2838–2851.
   PubMed Web of Science ®Google Scholar
• Geng DM, Kan XM, Zhang WW. Effect of ZEB2 silencing on cisplatin resistance in gastric cancer. Eur Rev Med Pharmacol Sci. 2017;21(8):1746–1752.
   PubMed Web of Science ®Google Scholar
• Usova EV, Kopantseva MR, Kostina MB, et al. Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state. Dokl Biol Sci. 2013;448:61–64.
   PubMedGoogle Scholar
• Zhu GJ, Song PP, Zhou H, et al. Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma. Oncol Lett. 2018;15(3):3472–3481.
   PubMed Web of Science ®Google Scholar
• Feng S, Liu W, Bai X, et al. LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer. Cancer Lett. 2019;465:105–117.
   PubMed Web of Science ®Google Scholar
• Gong P, Qiao F, Wu H, et al. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer. Cell Death Dis. 2018;9(12):1158.
   PubMed Web of Science ®Google Scholar